Novo Holdings A/S - 14 Jul 2023 Form 4 Insider Report for Cyteir Therapeutics, Inc.

Role
10%+ Owner
Signature
/s/ Barbara Fiorini Due, General Counsel, Finance & Operations of Novo Holdings A/S
Issuer symbol
N/A
Transactions as of
14 Jul 2023
Net transactions value
-$106,024
Form type
4
Filing time
18 Jul 2023, 20:27:47 UTC
Previous filing
03 Jul 2023
Next filing
20 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYT Common Stock Sale $30,102 -11,000 -0.3% $2.74 3,651,636 14 Jul 2023 Direct F1
transaction CYT Common Stock Sale $58,000 -21,100 -0.58% $2.75 3,630,536 17 Jul 2023 Direct F2
transaction CYT Common Stock Sale $17,923 -6,500 -0.18% $2.76 3,624,036 18 Jul 2023 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.73 to $2.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.74 to $2.7498, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.73 to $2.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.